CDK4 Cancer Research Results
CDK4, Cyclin-dependent kinase 4: Click to Expand ⟱
| Source: |
| Type: |
Cyclin-dependent kinase 4 (CDK4) is a key regulator of the cell cycle, particularly in the transition from the G1 phase to the S phase. Its expression and activity are often altered in various cancers, contributing to tumorigenesis.
CDK4 is frequently overexpressed in various cancers, and its expression levels can serve as a prognostic marker.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Var, |
NA |
|
|
|
- |
in-vitro, |
Nor, |
BV2 |
|
|
|
ROS⇅, ROS↑, ER Stress↑, Ca+2↑, Apoptosis↑, eff↑, DR5↑, 12LOX↓, Cyt‑c↑, Casp7↑, Casp9↑, Casp3↑, cl‑PARP↑, TumCCA↑, cycE/CCNE↑, CDK4↓, cycD1/CCND1↓, VEGF↓, cMyc↓, Hif1a↓, NF-kB↓, BioEnh↑, BioEnh↑, P450↓, *Hif1a↓, *iNOS↓, *COX2↓, *VEGF↓, *ROS↓, *PI3K↓, *Akt↓,
Inflam↓, IL6↓, MCP1↓, COX2↓, PGE2↓, MMP2↓, MMP9↓, DNAdam↑, eff↝, Telomerase↓, Bcl-2↓, AMPK↑, ROS↑, MMP↓, ATP↓, p‑mTORC1↓, p‑S6K↓, ERK↓, PI3K↓, PTEN↑, Akt↓, Raf↓, MEK↓, Dose↓, Dose↑, selectivity↑, TumCCA↑, eff↑, EGFR↓, Glycolysis↓, Dose?, p27↑, CDK2↓, CDK4↓, cycD1/CCND1↓, cycE/CCNE↓, Bax:Bcl2↑, Casp3↑, Casp9↑, VEGFR2↓, ChemoSen↑, eff↑, eff↑, PGE2↓, JAK2↓, STAT3↓, CXCR4↓, CCR7↓, uPA↓, CSCs↓, EMT↓, Diff↓, CD133↓, Nestin↓, n-MYC↓, NOTCH↓, SOX2↓, Hif1a↓, VEGF↓, RadioS↑,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 2, ROS⇅, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, MEK↓, 1, MMP↓, 1, Raf↓, 1,
Core Metabolism/Glycolysis ⓘ
12LOX↓, 1, AMPK↑, 1, cMyc↓, 1, Glycolysis↓, 1, p‑S6K↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 1, Bax:Bcl2↑, 1, Bcl-2↓, 1, Casp3↑, 2, Casp7↑, 1, Casp9↑, 2, Cyt‑c↑, 1, DR5↑, 1, p27↑, 1, Telomerase↓, 1,
Protein Folding & ER Stress ⓘ
ER Stress↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, CDK4↓, 2, cycD1/CCND1↓, 2, cycE/CCNE↓, 1, cycE/CCNE↑, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
CD133↓, 1, CSCs↓, 1, Diff↓, 1, EMT↓, 1, ERK↓, 1, p‑mTORC1↓, 1, n-MYC↓, 1, Nestin↓, 1, NOTCH↓, 1, PI3K↓, 1, PTEN↑, 1, SOX2↓, 1, STAT3↓, 1,
Migration ⓘ
Ca+2↑, 1, MMP2↓, 1, MMP9↓, 1, uPA↓, 1,
Angiogenesis & Vasculature ⓘ
EGFR↓, 1, Hif1a↓, 2, VEGF↓, 2, VEGFR2↓, 1,
Immune & Inflammatory Signaling ⓘ
CCR7↓, 1, COX2↓, 1, CXCR4↓, 1, IL6↓, 1, Inflam↓, 1, JAK2↓, 1, MCP1↓, 1, NF-kB↓, 1, PGE2↓, 2,
Drug Metabolism & Resistance ⓘ
BioEnh↑, 2, ChemoSen↑, 1, Dose?, 1, Dose↓, 1, Dose↑, 1, eff↑, 4, eff↝, 1, P450↓, 1, RadioS↑, 1, selectivity↑, 1,
Clinical Biomarkers ⓘ
EGFR↓, 1, IL6↓, 1,
Total Targets: 73
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
ROS↓, 1,
Cell Death ⓘ
Akt↓, 1, iNOS↓, 1,
Proliferation, Differentiation & Cell State ⓘ
PI3K↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1,
Total Targets: 7
Scientific Paper Hit Count for: CDK4, Cyclin-dependent kinase 4
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:894 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page